Androgenic Alopecia: Case Study and Treatment Analysis

    September 2010 in “ Journal of Men's Health
    Amber S Tully, Justin Schwartzenberger, James S. Studdiford
    Image of study
    TLDR Androgenic Alopecia, a common hair loss condition, can be effectively treated with finasteride and other treatments.
    The 2010 document discussed a case study of a 34-year-old man with Androgenic Alopecia (AGA), a common hair loss condition affecting up to 50% of men by age 50, caused by a genetically determined shortening of the hair growth phase. The study highlighted that AGA is androgen-dependent, with dihydrotestosterone (DHT) causing hair thinning and loss. The genetic factors and inheritance pattern of AGA were not fully understood. The document also explored treatments like Minoxidil and Finasteride. A daily 1 mg dose of finasteride increased hair weight by 21.5% above baseline at 96 weeks, with effects noticeable at 12 weeks. Side effects were minimal. A follow-up study showed a net increase of 46.1% in hair weight for the finasteride group. Other treatments like latanoprost and hair transplantation were also discussed. The study concluded that finasteride and other treatments could effectively treat AGA.
    Discuss this study in the Community →

    Research cited in this study

    22 / 22 results

    Related Community Posts Join

    6 / 1000+ results

      community Why is it that low testosterone causes hair loss as well? How can I be balding?

      in Chat  158 upvotes 7 months ago
      The conversation discusses the confusion over low testosterone potentially causing hair loss, with users sharing personal experiences and knowledge about hair loss treatments like Finasteride. Some users suggest that hair follicle sensitivity to DHT, not testosterone levels, is the key factor in balding, and others discuss the side effects of hair loss medications.

      community When are we getting a cure to hair loss?

      in Chat 1 year ago
      Potential treatments for hair loss, including Minoxidil, finasteride, RU58841 and various upcoming pharmaceuticals, gene editing and cloning. It is suggested that a cure, if found, would be highly profitable due to the large number of people affected by hair loss globally.

      community Received Kintor’s KX-826 Today

      in Product  84 upvotes 3 months ago
      A user received Kintor’s KX-826/Pyrilutamide and shared initial impressions, noting concerns about the product's labeling and marketing. Other users discussed the legitimacy of the product, its effectiveness, and compared it to other treatments like Minoxidil and Finasteride.

    Related Research

    4 / 4 results